Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 187.21B | 189.19B | 208.35B | 241.39B | 157.74B | 105.94B |
Gross Profit | 28.89B | 30.24B | 64.06B | 55.10B | 22.86B | 10.18B |
EBITDA | 26.99B | 27.98B | 43.50B | 59.47B | 32.55B | 14.54B |
Net Income | -1.20B | 381.00M | 15.24B | -1.36B | 7.57B | -20.73B |
Balance Sheet | ||||||
Total Assets | 281.40B | 282.23B | 280.29B | 288.12B | 287.27B | 267.65B |
Cash, Cash Equivalents and Short-Term Investments | 34.05B | 34.52B | 28.59B | 29.77B | 30.96B | 29.53B |
Total Debt | 71.13B | 71.55B | 63.08B | 55.49B | 69.79B | 81.93B |
Total Liabilities | 203.44B | 203.91B | 194.80B | 205.13B | 196.83B | 182.09B |
Stockholders Equity | 58.22B | 59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | ||||||
Free Cash Flow | 10.19B | 12.00B | 17.75B | 28.86B | 12.72B | -144.00M |
Operating Cash Flow | 25.12B | 27.30B | 32.04B | 40.93B | 23.61B | 12.16B |
Investing Cash Flow | -12.66B | -13.25B | -14.87B | -13.71B | -5.69B | -7.86B |
Financing Cash Flow | -9.99B | -7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £1.66B | 11.22 | 17.50% | 721.39% | -9.80% | -1.98% | |
79 Outperform | £1.39B | 10.23 | 9.56% | 3.70% | 89.44% | 540.95% | |
74 Outperform | £152.38B | 15.10 | 7.41% | 4.13% | -4.09% | -20.79% | |
69 Neutral | £3.41B | 21.62 | -2.87% | 3.81% | 29.33% | ― | |
68 Neutral | £2.62B | 15.84 | -5.65% | 23.63% | 1.04% | -156.59% | |
66 Neutral | £57.68B | 183.44 | -1.85% | 6.38% | -9.08% | -113.54% | |
52 Neutral | C$2.91B | -0.88 | -3.26% | 6.37% | 2.20% | -43.43% |